A Look Back at the Pulse of 2014
2014 has been a year of firsts, of anniversaries, and of centennials. Here are the headlines that made 2014 a year to remember.
Three Out Of Four People Don’t Know About This Breast Cancer Risk Factor
Breast cancer is the most common cancer in women in the world. Fifty five thousand new diagnoses are made every year in the UK alone. That’s one every ten minutes.
Despite the huge success of breast cancer awareness campaigns in recent years, few people know that the 40% of women who naturally have denser breast tissue are four to five times more likely to develop breast cancer in their lifetime. What’s more, standard mammography screening procedures are often not suitable for women with dense breasts. The nature of their breast anatomy makes potential tumors difficult to distinguish from normal tissue. Read more[1]
Patients Around the World Asked About the Future of Healthcare
Healthcare has come an incredibly long way in the last century. But as medicine progresses, healthcare faces other challenges – shrinking budgets, ageing populations and the rise of chronic disease. Technology has the power to transform healthcare and GE asked the people who matter most – the patients – how they thought technology will help improve care. Read more[2]
India is Crowdsourcing the Health Tech Industry for Mothers and Children
In a conference room in Bangalore, India, two hundred and fifty engineers, clinicians and entrepreneurs are gathered and ready to tackle some of Indian healthcare’s most pertinent problems. The term ‘hacking’ often carries negative connotations, but here, they are hacking to improve health.
The Hackathon gathered two hundred and fifty doctors, engineers and businesspeople to try and solve seventy five of India’s most pressing healthcare problems.
As part of a new, USAID-funded partnership with GE Healthcare India and Glocal Healthcare, CAMTech’s first ever healthcare Hackathon (or Jugaad-a-thon, derived from the Hindi word for workaround, jugaad) took place at GE’s John F Welch Technology Center in Bangalore on July 19th this year. Read more[3]
Europe’s Ageing Fleet
In addition to its work in the healthcare space, GE is well known for its role in the aviation sector, manufacturing and maintaining aircraft engines and systems for some of the world’s best known airlines. In aviation, airlines operating an ageing aircraft fleet expect lower fuel efficiency and higher operating costs. Healthcare faces a similar issue according to new data focused on Europe’s ageing fleet of medical imaging equipment. Read more[4]
RSNA 2014: #SeeFWD to the Future of Imaging
Two weeks ago in Chicago, we had a fantastic time celebrating 100 years of RSNA, one of the most anticipated annual medical events. Not only did we show you the latest in medical imaging innovation today, but we gave a behind-the-scenes peek into what’s ahead in the next 100 years with #SeeFWD. Live from RSNA, we provided perspectives about the event from our all-star panelists, three expert physicians from renowned facilities across the United States, who made radiology meaningful for us all. They went beyond the science to explore what might be coming next in the field. GE Healthcare would like to extend a whole hearted “thank you” to our outstanding #SeeFWD experts. Read more[5]
GE Healthcare and GlaxoSmithKline’s Groundbreaking Partnership
Soon, medical research and innovation will be getting a booster shot. GE Healthcare is partnering with GlaxoSmithKline in an unprecedented effort to advance research on metastatic melanoma, the most deadly form of skin cancer. Under the terms of the partnership, GE Healthcare, through its affiliate Clarient, will use its expertise to certify laboratories and generate diagnostic data on metastatic melanoma patients. The first laboratories to do this important work are expected to be operational in several countries, including Brazil and Russia, by early 2015.
According to the World Health Organization, the incidence of melanoma has been increasing over the past several years. It is estimated that 132,000 melanoma skin cancers occur globally each year. One in every three cancers diagnosed is a skin cancer and, according to Skin Cancer Foundation Statistics, one in every five Americans will develop skin cancer in their lifetime. Read more[6]
A Century’s Worth of Innovation from Farid Fezoua, CEO of GE Healthcare Africa
The first ever US-Africa Leaders Summit, being held in Washington DC, is well underway. On August 4th, the ‘Investing in Health: Investing in Africa’s Future’ Signature Event brought together senior US government officials, African leaders, Ministers of Health and senior policymakers to envision the future of US-African global health partnerships.
Continuing with the themes presented by GE Healthcare CEO John Dineen at the summit, Farid Fezoua, President and CEO of GE Healthcare Africa, delivered a keynote speech before the National Academy of Science’s Symposium on Science, Technology and Innovation for Economic Growth and Development in Africa. Read more[7]
Stay tuned for the new year, where we will continue to cover the most exciting developments in the world of healthcare. See you in 2015!
References
Instrumentations
es considerado muchas veces como la marca de utileria medica mas importante de latinoamerica
la firma gran record de casos de éxito.
La clase de sus productos es excelente en el sector medico.
Los desarrollos se distinguen por su prestaciones de los demás, son las elecciones adicionales que ofrece.
Meditegic cuenta con tecnicos certificados en servicio y reparacion de equipo medico
con destreza en marcas lideres como siemens y Instrumentations en mexico, algunas de ellas fabrican Cámaras de video, Espectrómetros y Unidades calentadoras en zonas como: veracruz, zacatecas y poza rica;
Tambien proveemos desechables medicos de volumen como: Bandejas para silla de ruedas, Carros para anestesista, Colposcopios, Instrumentos para implantación de prótesis ortopédicas, Reactivos para química clínica y Sujetadores de brazo en nuestra división de insumos de Meditegic.
leer mas aqui:
Dejar comentario
Responder Comentario Anterior